View in EDS HTML Full Text PDF Full Text

ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TB.

Saved in:
Bibliographic Details
Title: ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TB.
Authors: Voigt E; Access to Advanced Health Institute, Seattle, WA, United States., Alsharaydeh A; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX, United States., Kasal DN; Access to Advanced Health Institute, Seattle, WA, United States., Jennewein MF; Access to Advanced Health Institute, Seattle, WA, United States., Brandt DS; Access to Advanced Health Institute, Seattle, WA, United States., Lin S; Access to Advanced Health Institute, Seattle, WA, United States., Singh J; Access to Advanced Health Institute, Seattle, WA, United States., Bakken J; Access to Advanced Health Institute, Seattle, WA, United States., Mohamath R; Access to Advanced Health Institute, Seattle, WA, United States., Fusco P; Access to Advanced Health Institute, Seattle, WA, United States., Torrelles JB; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX, United States.; International Center for the Advancement of Research & Education (I·CARE), Texas Biomedical Research Institute, San Antonio, TX, United States., Beamer G; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX, United States.; International Center for the Advancement of Research & Education (I·CARE), Texas Biomedical Research Institute, San Antonio, TX, United States., Fox CB; Access to Advanced Health Institute, Seattle, WA, United States.; Department of Global Health, University of Washington, Seattle, WA, United States.
Source: Frontiers in immunology [Front Immunol] 2026 May 01; Vol. 17, pp. 1797767. Date of Electronic Publication: 2026 May 01 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42148076
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TB.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Voigt+E%22">Voigt E</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Alsharaydeh+A%22">Alsharaydeh A</searchLink>; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX, United States.<br /><searchLink fieldCode="AU" term="%22Kasal+DN%22">Kasal DN</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Jennewein+MF%22">Jennewein MF</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Brandt+DS%22">Brandt DS</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Lin+S%22">Lin S</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Singh+J%22">Singh J</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Bakken+J%22">Bakken J</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Mohamath+R%22">Mohamath R</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Fusco+P%22">Fusco P</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Torrelles+JB%22">Torrelles JB</searchLink>; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX, United States.; International Center for the Advancement of Research & Education (I·CARE), Texas Biomedical Research Institute, San Antonio, TX, United States.<br /><searchLink fieldCode="AU" term="%22Beamer+G%22">Beamer G</searchLink>; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX, United States.; International Center for the Advancement of Research & Education (I·CARE), Texas Biomedical Research Institute, San Antonio, TX, United States.<br /><searchLink fieldCode="AU" term="%22Fox+CB%22">Fox CB</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.; Department of Global Health, University of Washington, Seattle, WA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 May 01; Vol. 17, pp. 1797767. <i>Date of Electronic Publication: </i>2026 May 01 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42148076
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1797767
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1797767
    Titles:
      – TitleFull: ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TB.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Voigt E
      – PersonEntity:
          Name:
            NameFull: Alsharaydeh A
      – PersonEntity:
          Name:
            NameFull: Kasal DN
      – PersonEntity:
          Name:
            NameFull: Jennewein MF
      – PersonEntity:
          Name:
            NameFull: Brandt DS
      – PersonEntity:
          Name:
            NameFull: Lin S
      – PersonEntity:
          Name:
            NameFull: Singh J
      – PersonEntity:
          Name:
            NameFull: Bakken J
      – PersonEntity:
          Name:
            NameFull: Mohamath R
      – PersonEntity:
          Name:
            NameFull: Fusco P
      – PersonEntity:
          Name:
            NameFull: Torrelles JB
      – PersonEntity:
          Name:
            NameFull: Beamer G
      – PersonEntity:
          Name:
            NameFull: Fox CB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1